Indian Exports at Risk: US Plans 25% Tariff, Four Companies Most Exposed

India’s export sector faces a potential setback as the US considers imposing a 25% tariff on key imports, putting 27% of Indian exports at risk. The move is part of the Biden administration’s broader strategy to safeguard domestic industries and reduce reliance on foreign supply chains, particularly in sectors like pharmaceuticals, chemicals, auto components, and industrial goods. According to industry estimates, four Indian companies—

, , , and Sun Pharma —are among the most exposed to this tariff hike. These firms have significant revenue streams linked to the US market, and any increase in duties could impact their profitability. Sectors and Companies at Risk Automobile & Components: Major exporters like Tata Motors and Motherson Sumi supply key parts to the US auto industry. Higher tariffs could make Indian-made components less competitive. Pharmaceuticals: Sun Pharma, a leading Indian drug manufacturer with substantial US sales, may see pressure on its margins if import costs rise. Engineering & Industrial Goods: Bharat Forge, a major supplier of forged components, could be affected by increased costs for US buyers. What’s Next? Indian companies are closely monitoring trade negotiations, hoping for a resolution that mitigates the impact of these tariffs. If implemented, firms may explore alternative markets, local manufacturing in the US, or renegotiated contracts to absorb some costs. The Indian government is also expected to engage in diplomatic discussions to safeguard exporters’ interests. Source: The Economic Times No Recommendations